Atlas Trials

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

Clinical trial NCT06222853 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06222853
Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus ErythematosusCAR-T Cell Therapy
Start date
2024-02-10
Primary completion
2025-04-04
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.